Literature DB >> 26302676

Serine 403-phosphorylated p62/SQSTM1 immunoreactivity in inclusions of neurodegenerative diseases.

Masaru Kurosawa1, Gen Matsumoto2, Hiroyuki Sumikura3, Hiroyuki Hatsuta3, Shigeo Murayama3, Takashi Sakurai4, Tomomi Shimogori5, Nobutaka Hattori6, Nobuyuki Nukina7.   

Abstract

Protein inclusions in neurodegenerative diseases are associated with p62, which has an important role in autophagic clearance of polyubiquitinated proteins. Selective autophagy is regulated by S403-phosphorylation of p62, and S403-phosphorylated p62 (S403-phos-p62) accumulates in Atg5 conditional knockout (Atg5CKO) mice in which autophagosome formation is impaired. We performed immunohistochemical tests for the presence of S403-phos-p62 in postmortem brain of neurodegenerative disease cases, and found accumulations in amyotrophic lateral sclerosis and Alzheimer's disease tissues. In Atg5CKO and HD190QG (Huntington's disease model) mice, however, we found a postmortem decrease in S403-phos-p62 immunoreactivity, suggesting that post-mortem changes should be considered when interpreting human data.
Copyright © 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyotrophic lateral sclerosis; Dephosphorylation; Postmortem change; Protein degradation; Selective autophagy

Mesh:

Substances:

Year:  2015        PMID: 26302676     DOI: 10.1016/j.neures.2015.08.002

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  10 in total

1.  PTK2/FAK regulates UPS impairment via SQSTM1/p62 phosphorylation in TARDBP/TDP-43 proteinopathies.

Authors:  Shinrye Lee; Yu-Mi Jeon; Sun Joo Cha; Seyeon Kim; Younghwi Kwon; Myungjin Jo; You-Na Jang; Seongsoo Lee; Jaekwang Kim; Sang Ryong Kim; Kea Joo Lee; Sung Bae Lee; Kiyoung Kim; Hyung-Jun Kim
Journal:  Autophagy       Date:  2019-11-05       Impact factor: 16.016

Review 2.  L-Serine: a Naturally-Occurring Amino Acid with Therapeutic Potential.

Authors:  J S Metcalf; R A Dunlop; J T Powell; S A Banack; P A Cox
Journal:  Neurotox Res       Date:  2017-09-19       Impact factor: 3.911

Review 3.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

4.  HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Katsutoshi Taguchi; Masaki Tanaka
Journal:  Autophagy       Date:  2016-11-15       Impact factor: 16.016

5.  Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model.

Authors:  Shun Mitsui; Asako Otomo; Masahisa Nozaki; Suzuka Ono; Kai Sato; Ryohei Shirakawa; Hiroaki Adachi; Masashi Aoki; Gen Sobue; Hui-Fang Shang; Shinji Hadano
Journal:  Mol Brain       Date:  2018-05-29       Impact factor: 4.041

6.  N-Acyldopamine induces aggresome formation without proteasome inhibition and enhances protein aggregation via p62/SQSTM1 expression.

Authors:  Gen Matsumoto; Tomonao Inobe; Takanori Amano; Kiyohito Murai; Nobuyuki Nukina; Nozomu Mori
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

Review 7.  Mitophagy and the Brain.

Authors:  Natalie S Swerdlow; Heather M Wilkins
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

8.  Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway.

Authors:  Shiyuan Hong; Yan Li; Paul J Kaminski; Jorge Andrade; Laimonis A Laimins
Journal:  mBio       Date:  2020-08-12       Impact factor: 7.867

Review 9.  Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.

Authors:  Fang Luo; Aaron F Sandhu; Wiramon Rungratanawanich; George E Williams; Mohammed Akbar; Shuanhu Zhou; Byoung-Joon Song; Xin Wang
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

10.  Interaction between TRPML1 and p62 in Regulating Autophagosome-Lysosome Fusion and Impeding Neuroaxonal Dystrophy in Alzheimer's Disease.

Authors:  Lu Zhang; Yu Fang; Xuan Cheng; Yajun Lian; Hongliang Xu
Journal:  Oxid Med Cell Longev       Date:  2022-01-25       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.